Nebula Research & Development LLC
- SEC CIK
- 0001792635
- Latest filing
- May 15, 2026
GH holding history
Guardant Health, Inc. in every 13F filed by Nebula Research & Development LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GH overviewAll 13F holders of GHFull Q1 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −32,791−100.0% | Sold out | Holders |
| Q1 2025 | 32,791 | $1.40M | 0.1% | −19,054−36.8% | Reduced | Holders |
| Q4 2024 | 51,845 | $1.58M | 0.2% | +13,484+35.2% | Added | Holders |
| Q3 2024 | 38,361 | $880.0K | 0.1% | +38,361 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −70,328−100.0% | Sold out | Holders |
| Q1 2024 | 70,328 | $1.45M | 0.3% | +50,255+250.4% | Added | Holders |
| Q4 2023 | 20,073 | $543.0K | 0.2% | +5,698+39.6% | Added | Holders |
| Q3 2023 | 14,375 | $426.1K | 0.2% | +14,375 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −13,574−100.0% | Sold out | Holders |
| Q1 2023 | 13,574 | $318.2K | 0.6% | – | No prior filing | Holders |